查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1497623

CRISPR 基因編輯市場：按產品、技術、應用和最終用途分類 - 2024-2030 年全球預測

CRISPR Gene Editing Market by Offering (Reagents & Consumables, Services, Software & Systems), Technology (Anti-CRISPR Proteins, CRISPR/Cas13, CRISPR/Cas9), Application, End-use - Global Forecast 2024-2030
出版日期: | 出版商: 360iResearch | 英文 191 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計2023年CRISPR基因編輯市場規模為32.5億美元，2024年達到37.7億美元，預計2030年將達到96.6億美元，複合年成長率為16.81%。

CRISPR基因編輯，稱為CRISPR-Cas9，是一項突破性技術，允許遺傳學家和醫學研究人員透過添加、刪除或改變部分DNA序列來編輯和改變部分基因組。該技術是最簡單、最通用、最準確的基因操作方法之一。遺傳疾病盛行率的上升和對個人化醫療的需求不斷增加是推動市場成長的因素。此外，生物技術和製藥產業對研發的大量投資、政府和監管機構對基因編輯應用的支援在推動市場開拓方面發揮關鍵作用。然而，脫靶效應、圍繞人類種系編輯的倫理問題以及環境中可能出現的意外後果是限制市場成長的重大問題。此外，透過作物設計實現精密農業的進步以及細胞和基因研究方法的增強正在為市場成長創造利潤豐厚的機會。

主要市場統計
基準年[2023] 32.5億美元
預計年份 [2024] 37.7億美元
預測年份 [2030] 96.6億美元
複合年成長率（%） 16.81%

區域洞察

由於美洲地區，尤其是美國和加拿大，遺傳疾病和慢性病的盛行率很高，因此非常重視推進 CRISPR 技術。消費者的需求集中在個人化醫療和 CRISPR 新療法的潛力。美國在 CRISPR 專利方面處於領先地位，主要生物技術公司和著名學術機構都在進行引人注目的研究。歐盟 (EU) 國家擁有強而有力的法律規範指導生物技術的應用，影響消費者的需求和購買行為。一方面，嚴格法規的存在可以鼓勵徹底和安全的開發，但另一方面，它可能會減緩創新和採用。在中東和非洲地區，CRISPR技術仍處於採用的早期階段。由於經濟發展程度和醫療基礎設施不同，這些地區的消費者需求和客戶行為差異很大。亞太地區是一個多元化且快速發展的 CRISPR 基因編輯市場。在中國，CRISPR技術已獲得大量國家和私人投資，推動了大量研究和應用，特別是在醫學和農業領域。日本正在這一領域進行大力投資，將技術進步與考慮到社會對基因改造的擔憂的法規結合起來。

FPNV定位矩陣

FPNV定位矩陣對於評估CRISPR基因編輯市場供應商的市場定位至關重要。此矩陣提供了對供應商的全面評估，並檢驗了與業務策略和產品滿意度相關的關鍵指標。這種詳細的評估使用戶能夠根據自己的要求做出明智的決定。根據評估結果，供應商被分為代表其成功程度的四個像限：前沿（F）、探路者（P）、利基（N）和重要（V）。

市場佔有率分析

市場佔有率分析是一種綜合工具，可以對 CRISPR 基因編輯市場供應商的現狀進行深入而詳細的評估。透過仔細比較和分析供應商的貢獻，您可以更深入地了解每個供應商的績效以及他們在爭奪市場佔有率時面臨的挑戰。這些貢獻包括整體收益、客戶群和其他重要指標。此外，該分析還提供了對該行業競爭性質的寶貴見解，包括在研究基準年期間觀察到的累積、分散主導地位和合併特徵等因素。有了這些詳細資訊，供應商可以做出更明智的決策並製定有效的策略，以在市場競爭中保持領先地位。

策略分析與建議

策略分析對於尋求在全球市場站穩腳跟的組織至關重要。對 CRISPR 基因編輯市場當前地位的全面評估使公司能夠做出符合其長期願望的明智決策。此關鍵評估涉及對組織的資源、能力和整體績效進行徹底分析，以確定核心優勢和需要改進的領域。

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 對遺傳疾病新疫苗和治療方法的需求增加
      • 增加對生物技術和製藥領域的私人和公共投資
      • 在太空探勘中採用 CRISPR 基因編輯
    • 抑制因素
      • CRISPR療法的高成本
    • 機會
      • CRISPR 基因編輯的進展與改進
      • CRISPR基因編輯在農業的潛在應用
    • 任務
      • 與 CRISPR 基因編輯相關的技術挑戰和倫理問題
  • 市場區隔分析
    • 技術：CRISPR/Cas13 在涉及 RNA 操作的應用中越來越受歡迎
    • 最終用途：CRISPR 基因編輯在製藥和生物技術公司的治療方法開發和藥物發現中日益重要
  • 市場擾動分析
  • 波特五力分析
  • 價值鍊和關鍵路徑分析
  • 價格分析
  • 技術分析
  • 專利分析
  • 貿易分析
  • 法規結構分析

第6章 CRISPR 基因編輯市場：透過提供

  • 試劑/耗材
  • 服務
  • 軟體及系統

第7章 CRISPR 基因編輯市場：依技術分類

  • 抗CRISPR蛋白
  • 保鮮盒/Cas13
  • 保鮮盒/Cas9
  • CRISPR/Cpf1（Cas12a）

第8章 CRISPR 基因編輯市場：依應用分類

  • 診斷和治療發展
  • 基因工程

第 9 章 CRISPR 基因編輯市場：依最終用途

  • 學術研究所
  • 製藥和生物技術公司

第10章 美洲CRISPR基因編輯市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第11章 亞太地區CRISPR基因編輯市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第12章 歐洲、中東和非洲的CRISPR基因編輯市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第13章競爭格局

  • 2023 年市場佔有率分析
  • FPNV 定位矩陣，2023
  • 競爭情境分析
    • Synthego 和 SeQure Dx 合作為基於 CRISPR 的療法開發人員提供全面的脫靶分析服務
    • CRISPR QC 在 A 輪資金籌措中籌集 1000 萬美元
    • 新興企業Tome 以 2.5 億美元的基因編輯交易收購 Replace TX
  • 戰略分析和建議

第14章競爭產品組合

  • 主要企業簡介
  • 主要產品系列
Product Code: MRR-5C6F41F5AF91

[191 Pages Report] The CRISPR Gene Editing Market size was estimated at USD 3.25 billion in 2023 and expected to reach USD 3.77 billion in 2024, at a CAGR 16.81% to reach USD 9.66 billion by 2030.

CRISPR gene editing, referred to as CRISPR-Cas9, is a revolutionary biochemical technology that enables geneticists and medical researchers to edit and modify parts of the genome by adding, removing, and altering parts of the DNA sequence. It is one of the simplest, most versatile, and precise methods of genetic manipulation. The rising prevalence of genetic disorders, along with the increasing demand for personalized medicine, is owing to the market growth. Additionally, significant investments in research and development by biotech and pharma sectors and governmental and regulatory support for gene editing applications play a vital role in fostering market development. However, off-target effects, ethical concerns surrounding human germline editing, and the potential for unintended consequences in the environment are significant issues limiting the market growth. Furthermore, the advancement of precision agriculture through crop design and the enhancement of cellular and genetic research methods create lucrative opportunities for market growth.

KEY MARKET STATISTICS
Base Year [2023] USD 3.25 billion
Estimated Year [2024] USD 3.77 billion
Forecast Year [2030] USD 9.66 billion
CAGR (%) 16.81%

Regional Insights

In the Americas, particularly the United States and Canada, there is a significant emphasis on the advancement of CRISPR technology due to the high prevalence of genetic disorders and chronic diseases. Consumer needs are focused on personalized medicine and the potential of CRISPR to provide novel treatments. The United States is at the forefront in terms of CRISPR patents, with notable research being conducted by biotech giants and prestigious academic institutions. European Union (EU) countries have a robust regulatory framework guiding biotechnology applications that impact both consumer needs and purchasing behavior. The presence of stringent regulations, encouraging thorough, safe development on the one hand but potentially slowing innovation and adoption on the other. In the Middle East and Africa regions, CRISPR technology is still in the nascent stages of adoption. Due to varying levels of economic development and healthcare infrastructure, consumer needs and customer behavior differ significantly across these territories. The Asia Pacific region presents a diverse and rapidly evolving market for CRISPR gene editing. In China, CRISPR technology is receiving massive state and private investment, pushing forward substantial research and applications, especially in medicine and agriculture. Japan demonstrates a strong investment in the field, aligning its technological advancements with regulations sensitive to public concerns about genetic modification.

Market Insights

  • Market Dynamics

The market dynamics represent an ever-changing landscape of the CRISPR Gene Editing Market by providing actionable insights into factors, including supply and demand levels. Accounting for these factors helps design strategies, make investments, and formulate developments to capitalize on future opportunities. In addition, these factors assist in avoiding potential pitfalls related to political, geographical, technical, social, and economic conditions, highlighting consumer behaviors and influencing manufacturing costs and purchasing decisions.

    • Market Drivers
      • Growing need for new vaccines and treatments for genetic diseases
      • Increasing private and public investments in biotechnological and pharmaceutical sectors
      • Adoption of CRISPR gene editing in space investigation
    • Market Restraints
      • High cost of CRISPR therapies
    • Market Opportunities
      • Advancements and improvements in CRISPR gene editing
      • Potential use of CRISPR gene editing in the agriculture sector
    • Market Challenges
      • Technical challenges and ethical concerns associated with CRISPR gene editing
  • Market Segmentation Analysis
    • Technology: Increasing preference for CRISPR/Cas13 in application that involves the RNA manipulation
    • End-use: Growing significance of CRISPR gene editing in pharmaceutical and biotechnology firms for therapeutic development and drug discovery
  • Market Disruption Analysis
  • Porter's Five Forces Analysis
  • Value Chain & Critical Path Analysis
  • Pricing Analysis
  • Technology Analysis
  • Patent Analysis
  • Trade Analysis
  • Regulatory Framework Analysis

FPNV Positioning Matrix

The FPNV positioning matrix is essential in evaluating the market positioning of the vendors in the CRISPR Gene Editing Market. This matrix offers a comprehensive assessment of vendors, examining critical metrics related to business strategy and product satisfaction. This in-depth assessment empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success, namely Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The market share analysis is a comprehensive tool that provides an insightful and in-depth assessment of the current state of vendors in the CRISPR Gene Editing Market. By meticulously comparing and analyzing vendor contributions, companies are offered a greater understanding of their performance and the challenges they face when competing for market share. These contributions include overall revenue, customer base, and other vital metrics. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With these illustrative details, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Recent Developments

Synthego and SeQure Dx Partner to Provide Comprehensive Off-Target Analysis Services for CRISPR-Based Therapeutics Developers

Synthego and SeQure Dx formed a strategic alliance to advance the development of CRISPR therapeutics. This collaboration equips developers with an all-encompassing off-target editing analytic service, leveraging SeQure Dx's distinguished ONE-seq assay technology and Synthego's robust suite of synthetic guide RNAs. The seamless integration of these offerings promises to streamline the therapeutic development cycle, enhancing safety and efficiency while satisfying stringent regulatory standards. [Published On: 2024-01-23]

CRISPR QC Raises USD 10 Million in Series A Financing Round

CRISPR QC, a startup based in San Diego, concluded a Series A funding round with a significant USD 10 million investment. Specializing in assessing CRISPR/Cas9 gene-editing endeavors, CRISPR QC is pioneering the field with its innovative platform that utilizes the CRISPR-Chip, a high-precision biosensor designed to evaluate CRISPR activity accurately. This funding triumph comes from a seed funding round that garnered USD 1.6 million, reflecting growing confidence and interest in CRISPR QC's potential to transform gene editing quality control. [Published On: 2024-01-05]

Newcomer Tome Acquires Replace TX in USD 250 Million Gene Editing Deal

Tome Biosciences announced the acquisition of Replace Therapeutics in a strategic move, accelerating its footprint in the burgeoning gene editing sector. This acquisition underscores Tome's ambition to broaden its disease treatment portfolio and embodies the growing valuation of the gene editing market. Replace's contribution to Tome's suite with its ligase-mediated programmable genomic integration (L-PGI) complements Tome's existing large DNA edits, enhancing the company's capabilities in addressing various genetic conditions with high efficiency and specificity. [Published On: 2024-01-03]

Strategy Analysis & Recommendation

The strategic analysis is essential for organizations seeking a solid foothold in the global marketplace. Companies are better positioned to make informed decisions that align with their long-term aspirations by thoroughly evaluating their current standing in the CRISPR Gene Editing Market. This critical assessment involves a thorough analysis of the organization's resources, capabilities, and overall performance to identify its core strengths and areas for improvement.

Key Company Profiles

The report delves into recent significant developments in the CRISPR Gene Editing Market, highlighting leading vendors and their innovative profiles. These include Agilent Technologies, Inc., AstraZeneca PLC, Beam Therapeutics Inc., Bio-Rad Laboratories, Inc., Caribou Biosciences, Inc., Cellectis S.A., CRISPR Therapeutics AG, Danaher Corporation, Editas Medicine, Inc., F. Hoffmann-La Roche AG, GeneCopoeia, Inc., GenScript Biotech Corporation, Horizon Discovery Group Ltd. by Revvity, Inc., Inscripta, Inc., Intellia Therapeutics, Inc., Lonza Group Ltd., Mammoth Biosciences, Inc., Merck KGaA, New England Biolabs, Inc., OriGene Technologies, Inc., Prime Medicine, Inc., Qiagen NV, Sherlock Biosciences, Inc., Thermo Fisher Scientific Inc., and ToolGen, Inc..

Market Segmentation & Coverage

This research report categorizes the CRISPR Gene Editing Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Offering
    • Reagents & Consumables
    • Services
    • Software & Systems
  • Technology
    • Anti-CRISPR Proteins
    • CRISPR/Cas13
    • CRISPR/Cas9
    • CRISPR/Cpf1 (Cas12a)
  • Application
    • Diagnostics & Therapy Development
    • Genetic Engineering
      • Animal Genetic Engineering
      • Cell Line Engineering
      • Plant Genetic Engineering
  • End-use
    • Academic & Research Institutes
    • Pharmaceutical & Biotechnology Companies
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Growing need for new vaccines and treatments for genetic diseases
      • 5.1.1.2. Increasing private and public investments in biotechnological and pharmaceutical sectors
      • 5.1.1.3. Adoption of CRISPR gene editing in space investigation
    • 5.1.2. Restraints
      • 5.1.2.1. High cost of CRISPR therapies
    • 5.1.3. Opportunities
      • 5.1.3.1. Advancements and improvements in CRISPR gene editing
      • 5.1.3.2. Potential use of CRISPR gene editing in the agriculture sector
    • 5.1.4. Challenges
      • 5.1.4.1. Technical challenges and ethical concerns associated with CRISPR gene editing
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Technology: Increasing preference for CRISPR/Cas13 in application that involves the RNA manipulation
    • 5.2.2. End-use: Growing significance of CRISPR gene editing in pharmaceutical and biotechnology firms for therapeutic development and drug discovery
  • 5.3. Market Disruption Analysis
  • 5.4. Porter's Five Forces Analysis
    • 5.4.1. Threat of New Entrants
    • 5.4.2. Threat of Substitutes
    • 5.4.3. Bargaining Power of Customers
    • 5.4.4. Bargaining Power of Suppliers
    • 5.4.5. Industry Rivalry
  • 5.5. Value Chain & Critical Path Analysis
  • 5.6. Pricing Analysis
  • 5.7. Technology Analysis
  • 5.8. Patent Analysis
  • 5.9. Trade Analysis
  • 5.10. Regulatory Framework Analysis

6. CRISPR Gene Editing Market, by Offering

  • 6.1. Introduction
  • 6.2. Reagents & Consumables
  • 6.3. Services
  • 6.4. Software & Systems

7. CRISPR Gene Editing Market, by Technology

  • 7.1. Introduction
  • 7.2. Anti-CRISPR Proteins
  • 7.3. CRISPR/Cas13
  • 7.4. CRISPR/Cas9
  • 7.5. CRISPR/Cpf1 (Cas12a)

8. CRISPR Gene Editing Market, by Application

  • 8.1. Introduction
  • 8.2. Diagnostics & Therapy Development
  • 8.3. Genetic Engineering

9. CRISPR Gene Editing Market, by End-use

  • 9.1. Introduction
  • 9.2. Academic & Research Institutes
  • 9.3. Pharmaceutical & Biotechnology Companies

10. Americas CRISPR Gene Editing Market

  • 10.1. Introduction
  • 10.2. Argentina
  • 10.3. Brazil
  • 10.4. Canada
  • 10.5. Mexico
  • 10.6. United States

11. Asia-Pacific CRISPR Gene Editing Market

  • 11.1. Introduction
  • 11.2. Australia
  • 11.3. China
  • 11.4. India
  • 11.5. Indonesia
  • 11.6. Japan
  • 11.7. Malaysia
  • 11.8. Philippines
  • 11.9. Singapore
  • 11.10. South Korea
  • 11.11. Taiwan
  • 11.12. Thailand
  • 11.13. Vietnam

12. Europe, Middle East & Africa CRISPR Gene Editing Market

  • 12.1. Introduction
  • 12.2. Denmark
  • 12.3. Egypt
  • 12.4. Finland
  • 12.5. France
  • 12.6. Germany
  • 12.7. Israel
  • 12.8. Italy
  • 12.9. Netherlands
  • 12.10. Nigeria
  • 12.11. Norway
  • 12.12. Poland
  • 12.13. Qatar
  • 12.14. Russia
  • 12.15. Saudi Arabia
  • 12.16. South Africa
  • 12.17. Spain
  • 12.18. Sweden
  • 12.19. Switzerland
  • 12.20. Turkey
  • 12.21. United Arab Emirates
  • 12.22. United Kingdom

13. Competitive Landscape

  • 13.1. Market Share Analysis, 2023
  • 13.2. FPNV Positioning Matrix, 2023
  • 13.3. Competitive Scenario Analysis
    • 13.3.1. Synthego and SeQure Dx Partner to Provide Comprehensive Off-Target Analysis Services for CRISPR-Based Therapeutics Developers
    • 13.3.2. CRISPR QC Raises USD 10 Million in Series A Financing Round
    • 13.3.3. Newcomer Tome Acquires Replace TX in USD 250 Million Gene Editing Deal
  • 13.4. Strategy Analysis & Recommendation

14. Competitive Portfolio

  • 14.1. Key Company Profiles
  • 14.2. Key Product Portfolio

LIST OF FIGURES

  • FIGURE 1. CRISPR GENE EDITING MARKET RESEARCH PROCESS
  • FIGURE 2. CRISPR GENE EDITING MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL CRISPR GENE EDITING MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL CRISPR GENE EDITING MARKET SIZE, BY REGION, 2023 VS 2030 (%)
  • FIGURE 5. GLOBAL CRISPR GENE EDITING MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. CRISPR GENE EDITING MARKET DYNAMICS
  • FIGURE 7. GLOBAL CRISPR GENE EDITING MARKET SIZE, BY OFFERING, 2023 VS 2030 (%)
  • FIGURE 8. GLOBAL CRISPR GENE EDITING MARKET SIZE, BY OFFERING, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 9. GLOBAL CRISPR GENE EDITING MARKET SIZE, BY TECHNOLOGY, 2023 VS 2030 (%)
  • FIGURE 10. GLOBAL CRISPR GENE EDITING MARKET SIZE, BY TECHNOLOGY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 11. GLOBAL CRISPR GENE EDITING MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 12. GLOBAL CRISPR GENE EDITING MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 13. GLOBAL CRISPR GENE EDITING MARKET SIZE, BY END-USE, 2023 VS 2030 (%)
  • FIGURE 14. GLOBAL CRISPR GENE EDITING MARKET SIZE, BY END-USE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 15. AMERICAS CRISPR GENE EDITING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 16. AMERICAS CRISPR GENE EDITING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 17. UNITED STATES CRISPR GENE EDITING MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 18. UNITED STATES CRISPR GENE EDITING MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 19. ASIA-PACIFIC CRISPR GENE EDITING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 20. ASIA-PACIFIC CRISPR GENE EDITING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 21. EUROPE, MIDDLE EAST & AFRICA CRISPR GENE EDITING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 22. EUROPE, MIDDLE EAST & AFRICA CRISPR GENE EDITING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 23. CRISPR GENE EDITING MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 24. CRISPR GENE EDITING MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. CRISPR GENE EDITING MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL CRISPR GENE EDITING MARKET SIZE, 2018-2023 (USD MILLION)
  • TABLE 4. GLOBAL CRISPR GENE EDITING MARKET SIZE, 2024-2030 (USD MILLION)
  • TABLE 5. GLOBAL CRISPR GENE EDITING MARKET SIZE, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 6. GLOBAL CRISPR GENE EDITING MARKET SIZE, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 7. GLOBAL CRISPR GENE EDITING MARKET SIZE, BY OFFERING, 2018-2023 (USD MILLION)
  • TABLE 8. GLOBAL CRISPR GENE EDITING MARKET SIZE, BY OFFERING, 2024-2030 (USD MILLION)
  • TABLE 9. GLOBAL CRISPR GENE EDITING MARKET SIZE, BY REAGENTS & CONSUMABLES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 10. GLOBAL CRISPR GENE EDITING MARKET SIZE, BY REAGENTS & CONSUMABLES, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 11. GLOBAL CRISPR GENE EDITING MARKET SIZE, BY SERVICES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 12. GLOBAL CRISPR GENE EDITING MARKET SIZE, BY SERVICES, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 13. GLOBAL CRISPR GENE EDITING MARKET SIZE, BY SOFTWARE & SYSTEMS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 14. GLOBAL CRISPR GENE EDITING MARKET SIZE, BY SOFTWARE & SYSTEMS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 15. GLOBAL CRISPR GENE EDITING MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 16. GLOBAL CRISPR GENE EDITING MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 17. GLOBAL CRISPR GENE EDITING MARKET SIZE, BY ANTI-CRISPR PROTEINS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 18. GLOBAL CRISPR GENE EDITING MARKET SIZE, BY ANTI-CRISPR PROTEINS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 19. GLOBAL CRISPR GENE EDITING MARKET SIZE, BY CRISPR/CAS13, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 20. GLOBAL CRISPR GENE EDITING MARKET SIZE, BY CRISPR/CAS13, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 21. GLOBAL CRISPR GENE EDITING MARKET SIZE, BY CRISPR/CAS9, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 22. GLOBAL CRISPR GENE EDITING MARKET SIZE, BY CRISPR/CAS9, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 23. GLOBAL CRISPR GENE EDITING MARKET SIZE, BY CRISPR/CPF1 (CAS12A), BY REGION, 2018-2023 (USD MILLION)
  • TABLE 24. GLOBAL CRISPR GENE EDITING MARKET SIZE, BY CRISPR/CPF1 (CAS12A), BY REGION, 2024-2030 (USD MILLION)
  • TABLE 25. GLOBAL CRISPR GENE EDITING MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 26. GLOBAL CRISPR GENE EDITING MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 27. GLOBAL CRISPR GENE EDITING MARKET SIZE, BY DIAGNOSTICS & THERAPY DEVELOPMENT, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 28. GLOBAL CRISPR GENE EDITING MARKET SIZE, BY DIAGNOSTICS & THERAPY DEVELOPMENT, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 29. GLOBAL CRISPR GENE EDITING MARKET SIZE, BY GENETIC ENGINEERING, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 30. GLOBAL CRISPR GENE EDITING MARKET SIZE, BY GENETIC ENGINEERING, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 31. GLOBAL CRISPR GENE EDITING MARKET SIZE, BY GENETIC ENGINEERING, 2018-2023 (USD MILLION)
  • TABLE 32. GLOBAL CRISPR GENE EDITING MARKET SIZE, BY GENETIC ENGINEERING, 2024-2030 (USD MILLION)
  • TABLE 33. GLOBAL CRISPR GENE EDITING MARKET SIZE, BY ANIMAL GENETIC ENGINEERING, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 34. GLOBAL CRISPR GENE EDITING MARKET SIZE, BY ANIMAL GENETIC ENGINEERING, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 35. GLOBAL CRISPR GENE EDITING MARKET SIZE, BY CELL LINE ENGINEERING, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 36. GLOBAL CRISPR GENE EDITING MARKET SIZE, BY CELL LINE ENGINEERING, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 37. GLOBAL CRISPR GENE EDITING MARKET SIZE, BY PLANT GENETIC ENGINEERING, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 38. GLOBAL CRISPR GENE EDITING MARKET SIZE, BY PLANT GENETIC ENGINEERING, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 39. GLOBAL CRISPR GENE EDITING MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 40. GLOBAL CRISPR GENE EDITING MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 41. GLOBAL CRISPR GENE EDITING MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 42. GLOBAL CRISPR GENE EDITING MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 43. GLOBAL CRISPR GENE EDITING MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 44. GLOBAL CRISPR GENE EDITING MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 45. AMERICAS CRISPR GENE EDITING MARKET SIZE, BY OFFERING, 2018-2023 (USD MILLION)
  • TABLE 46. AMERICAS CRISPR GENE EDITING MARKET SIZE, BY OFFERING, 2024-2030 (USD MILLION)
  • TABLE 47. AMERICAS CRISPR GENE EDITING MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 48. AMERICAS CRISPR GENE EDITING MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 49. AMERICAS CRISPR GENE EDITING MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 50. AMERICAS CRISPR GENE EDITING MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 51. AMERICAS CRISPR GENE EDITING MARKET SIZE, BY GENETIC ENGINEERING, 2018-2023 (USD MILLION)
  • TABLE 52. AMERICAS CRISPR GENE EDITING MARKET SIZE, BY GENETIC ENGINEERING, 2024-2030 (USD MILLION)
  • TABLE 53. AMERICAS CRISPR GENE EDITING MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 54. AMERICAS CRISPR GENE EDITING MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 55. AMERICAS CRISPR GENE EDITING MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
  • TABLE 56. AMERICAS CRISPR GENE EDITING MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
  • TABLE 57. ARGENTINA CRISPR GENE EDITING MARKET SIZE, BY OFFERING, 2018-2023 (USD MILLION)
  • TABLE 58. ARGENTINA CRISPR GENE EDITING MARKET SIZE, BY OFFERING, 2024-2030 (USD MILLION)
  • TABLE 59. ARGENTINA CRISPR GENE EDITING MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 60. ARGENTINA CRISPR GENE EDITING MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 61. ARGENTINA CRISPR GENE EDITING MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 62. ARGENTINA CRISPR GENE EDITING MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 63. ARGENTINA CRISPR GENE EDITING MARKET SIZE, BY GENETIC ENGINEERING, 2018-2023 (USD MILLION)
  • TABLE 64. ARGENTINA CRISPR GENE EDITING MARKET SIZE, BY GENETIC ENGINEERING, 2024-2030 (USD MILLION)
  • TABLE 65. ARGENTINA CRISPR GENE EDITING MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 66. ARGENTINA CRISPR GENE EDITING MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 67. BRAZIL CRISPR GENE EDITING MARKET SIZE, BY OFFERING, 2018-2023 (USD MILLION)
  • TABLE 68. BRAZIL CRISPR GENE EDITING MARKET SIZE, BY OFFERING, 2024-2030 (USD MILLION)
  • TABLE 69. BRAZIL CRISPR GENE EDITING MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 70. BRAZIL CRISPR GENE EDITING MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 71. BRAZIL CRISPR GENE EDITING MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 72. BRAZIL CRISPR GENE EDITING MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 73. BRAZIL CRISPR GENE EDITING MARKET SIZE, BY GENETIC ENGINEERING, 2018-2023 (USD MILLION)
  • TABLE 74. BRAZIL CRISPR GENE EDITING MARKET SIZE, BY GENETIC ENGINEERING, 2024-2030 (USD MILLION)
  • TABLE 75. BRAZIL CRISPR GENE EDITING MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 76. BRAZIL CRISPR GENE EDITING MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 77. CANADA CRISPR GENE EDITING MARKET SIZE, BY OFFERING, 2018-2023 (USD MILLION)
  • TABLE 78. CANADA CRISPR GENE EDITING MARKET SIZE, BY OFFERING, 2024-2030 (USD MILLION)
  • TABLE 79. CANADA CRISPR GENE EDITING MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 80. CANADA CRISPR GENE EDITING MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 81. CANADA CRISPR GENE EDITING MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 82. CANADA CRISPR GENE EDITING MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 83. CANADA CRISPR GENE EDITING MARKET SIZE, BY GENETIC ENGINEERING, 2018-2023 (USD MILLION)
  • TABLE 84. CANADA CRISPR GENE EDITING MARKET SIZE, BY GENETIC ENGINEERING, 2024-2030 (USD MILLION)
  • TABLE 85. CANADA CRISPR GENE EDITING MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 86. CANADA CRISPR GENE EDITING MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 87. MEXICO CRISPR GENE EDITING MARKET SIZE, BY OFFERING, 2018-2023 (USD MILLION)
  • TABLE 88. MEXICO CRISPR GENE EDITING MARKET SIZE, BY OFFERING, 2024-2030 (USD MILLION)
  • TABLE 89. MEXICO CRISPR GENE EDITING MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 90. MEXICO CRISPR GENE EDITING MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 91. MEXICO CRISPR GENE EDITING MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 92. MEXICO CRISPR GENE EDITING MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 93. MEXICO CRISPR GENE EDITING MARKET SIZE, BY GENETIC ENGINEERING, 2018-2023 (USD MILLION)
  • TABLE 94. MEXICO CRISPR GENE EDITING MARKET SIZE, BY GENETIC ENGINEERING, 2024-2030 (USD MILLION)
  • TABLE 95. MEXICO CRISPR GENE EDITING MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 96. MEXICO CRISPR GENE EDITING MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 97. UNITED STATES CRISPR GENE EDITING MARKET SIZE, BY OFFERING, 2018-2023 (USD MILLION)
  • TABLE 98. UNITED STATES CRISPR GENE EDITING MARKET SIZE, BY OFFERING, 2024-2030 (USD MILLION)
  • TABLE 99. UNITED STATES CRISPR GENE EDITING MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 100. UNITED STATES CRISPR GENE EDITING MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 101. UNITED STATES CRISPR GENE EDITING MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 102. UNITED STATES CRISPR GENE EDITING MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 103. UNITED STATES CRISPR GENE EDITING MARKET SIZE, BY GENETIC ENGINEERING, 2018-2023 (USD MILLION)
  • TABLE 104. UNITED STATES CRISPR GENE EDITING MARKET SIZE, BY GENETIC ENGINEERING, 2024-2030 (USD MILLION)
  • TABLE 105. UNITED STATES CRISPR GENE EDITING MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 106. UNITED STATES CRISPR GENE EDITING MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 107. UNITED STATES CRISPR GENE EDITING MARKET SIZE, BY STATE, 2018-2023 (USD MILLION)
  • TABLE 108. UNITED STATES CRISPR GENE EDITING MARKET SIZE, BY STATE, 2024-2030 (USD MILLION)
  • TABLE 109. ASIA-PACIFIC CRISPR GENE EDITING MARKET SIZE, BY OFFERING, 2018-2023 (USD MILLION)
  • TABLE 110. ASIA-PACIFIC CRISPR GENE EDITING MARKET SIZE, BY OFFERING, 2024-2030 (USD MILLION)
  • TABLE 111. ASIA-PACIFIC CRISPR GENE EDITING MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 112. ASIA-PACIFIC CRISPR GENE EDITING MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 113. ASIA-PACIFIC CRISPR GENE EDITING MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 114. ASIA-PACIFIC CRISPR GENE EDITING MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 115. ASIA-PACIFIC CRISPR GENE EDITING MARKET SIZE, BY GENETIC ENGINEERING, 2018-2023 (USD MILLION)
  • TABLE 116. ASIA-PACIFIC CRISPR GENE EDITING MARKET SIZE, BY GENETIC ENGINEERING, 2024-2030 (USD MILLION)
  • TABLE 117. ASIA-PACIFIC CRISPR GENE EDITING MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 118. ASIA-PACIFIC CRISPR GENE EDITING MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 119. ASIA-PACIFIC CRISPR GENE EDITING MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
  • TABLE 120. ASIA-PACIFIC CRISPR GENE EDITING MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
  • TABLE 121. AUSTRALIA CRISPR GENE EDITING MARKET SIZE, BY OFFERING, 2018-2023 (USD MILLION)
  • TABLE 122. AUSTRALIA CRISPR GENE EDITING MARKET SIZE, BY OFFERING, 2024-2030 (USD MILLION)
  • TABLE 123. AUSTRALIA CRISPR GENE EDITING MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 124. AUSTRALIA CRISPR GENE EDITING MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 125. AUSTRALIA CRISPR GENE EDITING MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 126. AUSTRALIA CRISPR GENE EDITING MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 127. AUSTRALIA CRISPR GENE EDITING MARKET SIZE, BY GENETIC ENGINEERING, 2018-2023 (USD MILLION)
  • TABLE 128. AUSTRALIA CRISPR GENE EDITING MARKET SIZE, BY GENETIC ENGINEERING, 2024-2030 (USD MILLION)
  • TABLE 129. AUSTRALIA CRISPR GENE EDITING MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 130. AUSTRALIA CRISPR GENE EDITING MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 131. CHINA CRISPR GENE EDITING MARKET SIZE, BY OFFERING, 2018-2023 (USD MILLION)
  • TABLE 132. CHINA CRISPR GENE EDITING MARKET SIZE, BY OFFERING, 2024-2030 (USD MILLION)
  • TABLE 133. CHINA CRISPR GENE EDITING MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 134. CHINA CRISPR GENE EDITING MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 135. CHINA CRISPR GENE EDITING MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 136. CHINA CRISPR GENE EDITING MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 137. CHINA CRISPR GENE EDITING MARKET SIZE, BY GENETIC ENGINEERING, 2018-2023 (USD MILLION)
  • TABLE 138. CHINA CRISPR GENE EDITING MARKET SIZE, BY GENETIC ENGINEERING, 2024-2030 (USD MILLION)
  • TABLE 139. CHINA CRISPR GENE EDITING MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 140. CHINA CRISPR GENE EDITING MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 141. INDIA CRISPR GENE EDITING MARKET SIZE, BY OFFERING, 2018-2023 (USD MILLION)
  • TABLE 142. INDIA CRISPR GENE EDITING MARKET SIZE, BY OFFERING, 2024-2030 (USD MILLION)
  • TABLE 143. INDIA CRISPR GENE EDITING MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 144. INDIA CRISPR GENE EDITING MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 145. INDIA CRISPR GENE EDITING MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 146. INDIA CRISPR GENE EDITING MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 147. INDIA CRISPR GENE EDITING MARKET SIZE, BY GENETIC ENGINEERING, 2018-2023 (USD MILLION)
  • TABLE 148. INDIA CRISPR GENE EDITING MARKET SIZE, BY GENETIC ENGINEERING, 2024-2030 (USD MILLION)
  • TABLE 149. INDIA CRISPR GENE EDITING MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 150. INDIA CRISPR GENE EDITING MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 151. INDONESIA CRISPR GENE EDITING MARKET SIZE, BY OFFERING, 2018-2023 (USD MILLION)
  • TABLE 152. INDONESIA CRISPR GENE EDITING MARKET SIZE, BY OFFERING, 2024-2030 (USD MILLION)
  • TABLE 153. INDONESIA CRISPR GENE EDITING MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 154. INDONESIA CRISPR GENE EDITING MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 155. INDONESIA CRISPR GENE EDITING MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 156. INDONESIA CRISPR GENE EDITING MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 157. INDONESIA CRISPR GENE EDITING MARKET SIZE, BY GENETIC ENGINEERING, 2018-2023 (USD MILLION)
  • TABLE 158. INDONESIA CRISPR GENE EDITING MARKET SIZE, BY GENETIC ENGINEERING, 2024-2030 (USD MILLION)
  • TABLE 159. INDONESIA CRISPR GENE EDITING MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 160. INDONESIA CRISPR GENE EDITING MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 161. JAPAN CRISPR GENE EDITING MARKET SIZE, BY OFFERING, 2018-2023 (USD MILLION)
  • TABLE 162. JAPAN CRISPR GENE EDITING MARKET SIZE, BY OFFERING, 2024-2030 (USD MILLION)
  • TABLE 163. JAPAN CRISPR GENE EDITING MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 164. JAPAN CRISPR GENE EDITING MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 165. JAPAN CRISPR GENE EDITING MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 166. JAPAN CRISPR GENE EDITING MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 167. JAPAN CRISPR GENE EDITING MARKET SIZE, BY GENETIC ENGINEERING, 2018-2023 (USD MILLION)
  • TABLE 168. JAPAN CRISPR GENE EDITING MARKET SIZE, BY GENETIC ENGINEERING, 2024-2030 (USD MILLION)
  • TABLE 169. JAPAN CRISPR GENE EDITING MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 170. JAPAN CRISPR GENE EDITING MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 171. MALAYSIA CRISPR GENE EDITING MARKET SIZE, BY OFFERING, 2018-2023 (USD MILLION)
  • TABLE 172. MALAYSIA CRISPR GENE EDITING MARKET SIZE, BY OFFERING, 2024-2030 (USD MILLION)
  • TABLE 173. MALAYSIA CRISPR GENE EDITING MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 174. MALAYSIA CRISPR GENE EDITING MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 175. MALAYSIA CRISPR GENE EDITING MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 176. MALAYSIA CRISPR GENE EDITING MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 177. MALAYSIA CRISPR GENE EDITING MARKET SIZE, BY GENETIC ENGINEERING, 2018-2023 (USD MILLION)
  • TABLE 178. MALAYSIA CRISPR GENE EDITING MARKET SIZE, BY GENETIC ENGINEERING, 2024-2030 (USD MILLION)
  • TABLE 179. MALAYSIA CRISPR GENE EDITING MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 180. MALAYSIA CRISPR GENE EDITING MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 181. PHILIPPINES CRISPR GENE EDITING MARKET SIZE, BY OFFERING, 2018-2023 (USD MILLION)
  • TABLE 182. PHILIPPINES CRISPR GENE EDITING MARKET SIZE, BY OFFERING, 2024-2030 (USD MILLION)
  • TABLE 183. PHILIPPINES CRISPR GENE EDITING MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 184. PHILIPPINES CRISPR GENE EDITING MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 185. PHILIPPINES CRISPR GENE EDITING MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 186. PHILIPPINES CRISPR GENE EDITING MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 187. PHILIPPINES CRISPR GENE EDITING MARKET SIZE, BY GENETIC ENGINEERING, 2018-2023 (USD MILLION)
  • TABLE 188. PHILIPPINES CRISPR GENE EDITING MARKET SIZE, BY GENETIC ENGINEERING, 2024-2030 (USD MILLION)
  • TABLE 189. PHILIPPINES CRISPR GENE EDITING MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 190. PHILIPPINES CRISPR GENE EDITING MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 191. SINGAPORE CRISPR GENE EDITING MARKET SIZE, BY OFFERING, 2018-2023 (USD MILLION)
  • TABLE 192. SINGAPORE CRISPR GENE EDITING MARKET SIZE, BY OFFERING, 2024-2030 (USD MILLION)
  • TABLE 193. SINGAPORE CRISPR GENE EDITING MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 194. SINGAPORE CRISPR GENE EDITING MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 195. SINGAPORE CRISPR GENE EDITING MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 196. SINGAPORE CRISPR GENE EDITING MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 197. SINGAPORE CRISPR GENE EDITING MARKET SIZE, BY GENETIC ENGINEERING, 2018-2023 (USD MILLION)
  • TABLE 198. SINGAPORE CRISPR GENE EDITING MARKET SIZE, BY GENETIC ENGINEERING, 2024-2030 (USD MILLION)
  • TABLE 199. SINGAPORE CRISPR GENE EDITING MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 200. SINGAPORE CRISPR GENE EDITING MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 201. SOUTH KOREA CRISPR GENE EDITING MARKET SIZE, BY OFFERING, 2018-2023 (USD MILLION)
  • TABLE 202. SOUTH KOREA CRISPR GENE EDITING MARKET SIZE, BY OFFERING, 2024-2030 (USD MILLION)
  • TABLE 203. SOUTH KOREA CRISPR GENE EDITING MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 204. SOUTH KOREA CRISPR GENE EDITING MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 205. SOUTH KOREA CRISPR GENE EDITING MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 206. SOUTH KOREA CRISPR GENE EDITING MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 207. SOUTH KOREA CRISPR GENE EDITING MARKET SIZE, BY GENETIC ENGINEERING, 2018-2023 (USD MILLION)
  • TABLE 208. SOUTH KOREA CRISPR GENE EDITING MARKET SIZE, BY GENETIC ENGINEERING, 2024-2030 (USD MILLION)
  • TABLE 209. SOUTH KOREA CRISPR GENE EDITING MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 210. SOUTH KOREA CRISPR GENE EDITING MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 211. TAIWAN CRISPR GENE EDITING MARKET SIZE, BY OFFERING, 2018-2023 (USD MILLION)
  • TABLE 212. TAIWAN CRISPR GENE EDITING MARKET SIZE, BY OFFERING, 2024-2030 (USD MILLION)
  • TABLE 213. TAIWAN CRISPR GENE EDITING MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 214. TAIWAN CRISPR GENE EDITING MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 215. TAIWAN CRISPR GENE EDITING MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 216. TAIWAN CRISPR GENE EDITING MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 217. TAIWAN CRISPR GENE EDITING MARKET SIZE, BY GENETIC ENGINEERING, 2018-2023 (USD MILLION)
  • TABLE 218. TAIWAN CRISPR GENE EDITING MARKET SIZE, BY GENETIC ENGINEERING, 2024-2030 (USD MILLION)
  • TABLE 219. TAIWAN CRISPR GENE EDITING MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 220. TAIWAN CRISPR GENE EDITING MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 221. THAILAND CRISPR GENE EDITING MARKET SIZE, BY OFFERING, 2018-2023 (USD MILLION)
  • TABLE 222. THAILAND CRISPR GENE EDITING MARKET SIZE, BY OFFERING, 2024-2030 (USD MILLION)
  • TABLE 223. THAILAND CRISPR GENE EDITING MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 224. THAILAND CRISPR GENE EDITING MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 225. THAILAND CRISPR GENE EDITING MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 226. THAILAND CRISPR GENE EDITING MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 227. THAILAND CRISPR GENE EDITING MARKET SIZE, BY GENETIC ENGINEERING, 2018-2023 (USD MILLION)
  • TABLE 228. THAILAND CRISPR GENE EDITING MARKET SIZE, BY GENETIC ENGINEERING, 2024-2030 (USD MILLION)
  • TABLE 229. THAILAND CRISPR GENE EDITING MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 230. THAILAND CRISPR GENE EDITING MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 231. VIETNAM CRISPR GENE EDITING MARKET SIZE, BY OFFERING, 2018-2023 (USD MILLION)
  • TABLE 232. VIETNAM CRISPR GENE EDITING MARKET SIZE, BY OFFERING, 2024-2030 (USD MILLION)
  • TABLE 233. VIETNAM CRISPR GENE EDITING MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 234. VIETNAM CRISPR GENE EDITING MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 235. VIETNAM CRISPR GENE EDITING MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 236. VIETNAM CRISPR GENE EDITING MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 237. VIETNAM CRISPR GENE EDITING MARKET SIZE, BY GENETIC ENGINEERING, 2018-2023 (USD MILLION)
  • TABLE 238. VIETNAM CRISPR GENE EDITING MARKET SIZE, BY GENETIC ENGINEERING, 2024-2030 (USD MILLION)
  • TABLE 239. VIETNAM CRISPR GENE EDITING MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 240. VIETNAM CRISPR GENE EDITING MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 241. EUROPE, MIDDLE EAST & AFRICA CRISPR GENE EDITING MARKET SIZE, BY OFFERING, 2018-2023 (USD MILLION)
  • TABLE 242. EUROPE, MIDDLE EAST & AFRICA CRISPR GENE EDITING MARKET SIZE, BY OFFERING, 2024-2030 (USD MILLION)
  • TABLE 243. EUROPE, MIDDLE EAST & AFRICA CRISPR GENE EDITING MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 244. EUROPE, MIDDLE EAST & AFRICA CRISPR GENE EDITING MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 245. EUROPE, MIDDLE EAST & AFRICA CRISPR GENE EDITING MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 246. EUROPE, MIDDLE EAST & AFRICA CRISPR GENE EDITING MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 247. EUROPE, MIDDLE EAST & AFRICA CRISPR GENE EDITING MARKET SIZE, BY GENETIC ENGINEERING, 2018-2023 (USD MILLION)
  • TABLE 248. EUROPE, MIDDLE EAST & AFRICA CRISPR GENE EDITING MARKET SIZE, BY GENETIC ENGINEERING, 2024-2030 (USD MILLION)
  • TABLE 249. EUROPE, MIDDLE EAST & AFRICA CRISPR GENE EDITING MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 250. EUROPE, MIDDLE EAST & AFRICA CRISPR GENE EDITING MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 251. EUROPE, MIDDLE EAST & AFRICA CRISPR GENE EDITING MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
  • TABLE 252. EUROPE, MIDDLE EAST & AFRICA CRISPR GENE EDITING MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
  • TABLE 253. DENMARK CRISPR GENE EDITING MARKET SIZE, BY OFFERING, 2018-2023 (USD MILLION)
  • TABLE 254. DENMARK CRISPR GENE EDITING MARKET SIZE, BY OFFERING, 2024-2030 (USD MILLION)
  • TABLE 255. DENMARK CRISPR GENE EDITING MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 256. DENMARK CRISPR GENE EDITING MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 257. DENMARK CRISPR GENE EDITING MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 258. DENMARK CRISPR GENE EDITING MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 259. DENMARK CRISPR GENE EDITING MARKET SIZE, BY GENETIC ENGINEERING, 2018-2023 (USD MILLION)
  • TABLE 260. DENMARK CRISPR GENE EDITING MARKET SIZE, BY GENETIC ENGINEERING, 2024-2030 (USD MILLION)
  • TABLE 261. DENMARK CRISPR GENE EDITING MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 262. DENMARK CRISPR GENE EDITING MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 263. EGYPT CRISPR GENE EDITING MARKET SIZE, BY OFFERING, 2018-2023 (USD MILLION)
  • TABLE 264. EGYPT CRISPR GENE EDITING MARKET SIZE, BY OFFERING, 2024-2030 (USD MILLION)
  • TABLE 265. EGYPT CRISPR GENE EDITING MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 266. EGYPT CRISPR GENE EDITING MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 267. EGYPT CRISPR GENE EDITING MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 268. EGYPT CRISPR GENE EDITING MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 269. EGYPT CRISPR GENE EDITING MARKET SIZE, BY GENETIC ENGINEERING, 2018-2023 (USD MILLION)
  • TABLE 270. EGYPT CRISPR GENE EDITING MARKET SIZE, BY GENETIC ENGINEERING, 2024-2030 (USD MILLION)
  • TABLE 271. EGYPT CRISPR GENE EDITING MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 272. EGYPT CRISPR GENE EDITING MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 273. FINLAND CRISPR GENE EDITING MARKET SIZE, BY OFFERING, 2018-2023 (USD MILLION)
  • TABLE 274. FINLAND CRISPR GENE EDITING MARKET SIZE, BY OFFERING, 2024-2030 (USD MILLION)
  • TABLE 275. FINLAND CRISPR GENE EDITING MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 276. FINLAND CRISPR GENE EDITING MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 277. FINLAND CRISPR GENE EDITING MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 278. FINLAND CRISPR GENE EDITING MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 279. FINLAND CRISPR GENE EDITING MARKET SIZE, BY GENETIC ENGINEERING, 2018-2023 (USD MILLION)
  • TABLE 280. FINLAND CRISPR GENE EDITING MARKET SIZE, BY GENETIC ENGINEERING, 2024-2030 (USD MILLION)
  • TABLE 281. FINLAND CRISPR GENE EDITING MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 282. FINLAND CRISPR GENE EDITING MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 283. FRANCE CRISPR GENE EDITING MARKET SIZE, BY OFFERING, 2018-2023 (USD MILLION)
  • TABLE 284. FRANCE CRISPR GENE EDITING MARKET SIZE, BY OFFERING, 2024-2030 (USD MILLION)
  • TABLE 285. FRANCE CRISPR GENE EDITING MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 286. FRANCE CRISPR GENE EDITING MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 287. FRANCE CRISPR GENE EDITING MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 288. FRANCE CRISPR GENE EDITING MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 289. FRANCE CRISPR GENE EDITING MARKET SIZE, BY GENETIC ENGINEERING, 2018-2023 (USD MILLION)
  • TABLE 290. FRANCE CRISPR GENE EDITING MARKET SIZE, BY GENETIC ENGINEERING, 2024-2030 (USD MILLION)
  • TABLE 291. FRANCE CRISPR GENE EDITING MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 292. FRANCE CRISPR GENE EDITING MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 293. GERMANY CRISPR GENE EDITING MARKET SIZE, BY OFFERING, 2018-2023 (USD MILLION)
  • TABLE 294. GERMANY CRISPR GENE EDITING MARKET SIZE, BY OFFERING, 2024-2030 (USD MILLION)
  • TABLE 295. GERMANY CRISPR GENE EDITING MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 296. GERMANY CRISPR GENE EDITING MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 297. GERMANY CRISPR GENE EDITING MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 298. GERMANY CRISPR GENE EDITING MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 299. GERMANY CRISPR GENE EDITING MARKET SIZE, BY GENETIC ENGINEERING, 2018-2023 (USD MILLION)
  • TABLE 300. GERMANY CRISPR GENE EDITING MARKET SIZE, BY GENETIC ENGINEERING, 2024-2030 (USD MILLION)
  • TABLE 301. GERMANY CRISPR GENE EDITING MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 302. GERMANY CRISPR GENE EDITING MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 303. ISRAEL CRISPR GENE EDITING MARKET SIZE, BY OFFERING, 2018-2023 (USD MILLION)
  • TABLE 304. ISRAEL CRISPR GENE EDITING MARKET SIZE, BY OFFERING, 2024-2030 (USD MILLION)
  • TABLE 305. ISRAEL CRISPR GENE EDITING MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 306. ISRAEL CRISPR GENE EDITING MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 307. ISRAEL CRISPR GENE EDITING MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 308. ISRAEL CRISPR GENE EDITING MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 309. ISRAEL CRISPR GENE EDITING MARKET SIZE, BY GENETIC ENGINEERING, 2018-2023 (USD MILLION)
  • TABLE 310. ISRAEL CRISPR GENE EDITING MARKET SIZE, BY GENETIC ENGINEERING, 2024-2030 (USD MILLION)
  • TABLE 311. ISRAEL CRISPR GENE EDITING MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 312. ISRAEL CRISPR GENE EDITING MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 313. ITALY CRISPR GENE EDITING MARKET SIZE, BY OFFERING, 2018-2023 (USD MILLION)
  • TABLE 314. ITALY CRISPR GENE EDITING MARKET SIZE, BY OFFERING, 2024-2030 (USD MILLION)
  • TABLE 315. ITALY CRISPR GENE EDITING MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 316. ITALY CRISPR GENE EDITING MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 317. ITALY CRISPR GENE EDITING MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 318. ITALY CRISPR GENE EDITING MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 319. ITALY CRISPR GENE EDITING MARKET SIZE, BY GENETIC ENGINEERING, 2018-2023 (USD MILLION)
  • TABLE 320. ITALY CRISPR GENE EDITING MARKET SIZE, BY GENETIC ENGINEERING, 2024-2030 (USD MILLION)
  • TABLE 321. ITALY CRISPR GENE EDITING MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 322. ITALY CRISPR GENE EDITING MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 323. NETHERLANDS CRISPR GENE EDITING MARKET SIZE, BY OFFERING, 2018-2023 (USD MILLION)
  • TABLE 324. NETHERLANDS CRISPR GENE EDITING MARKET SIZE, BY OFFERING, 2024-2030 (USD MILLION)
  • TABLE 325. NETHERLANDS CRISPR GENE EDITING MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 326. NETHERLANDS CRISPR GENE EDITING MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 327. NETHERLANDS CRISPR GENE EDITING MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 328. NETHERLANDS CRISPR GENE EDITING MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 329. NETHERLANDS CRISPR GENE EDITING MARKET SIZE, BY GENETIC ENGINEERING, 2018-2023 (USD MILLION)
  • TABLE 330. NETHERLANDS CRISPR GENE EDITING MARKET SIZE, BY GENETIC ENGINEERING, 2024-2030 (USD MILLION)
  • TABLE 331. NETHERLANDS CRISPR GENE EDITING MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 332. NETHERLANDS CRISPR GENE EDITING MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 333. NIGERIA CRISPR GENE EDITING MARKET SIZE, BY OFFERING, 2018-2023 (USD MILLION)
  • TABLE 334. NIGERIA CRISPR GENE EDITING MARKET SIZE, BY OFFERING, 2024-2030 (USD MILLION)
  • TABLE 335. NIGERIA CRISPR GENE EDITING MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 336. NIGERIA CRISPR GENE EDITING MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 337. NIGERIA CRISPR GENE EDITING MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 338. NIGERIA CRISPR GENE EDITING MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 339. NIGERIA CRISPR GENE EDITING MARKET SIZE, BY GENETIC ENGINEERING, 2018-2023 (USD MILLION)
  • TABLE 340. NIGERIA CRISPR GENE EDITING MARKET SIZE, BY GENETIC ENGINEERING, 2024-2030 (USD MILLION)
  • TABLE 341. NIGERIA CRISPR GENE EDITING MARKET SIZE, BY END-USE, 2018-2023 (USD MILLION)
  • TABLE 342. NIGERIA CRISPR GENE EDITING MARKET SIZE, BY END-USE, 2024-2030 (USD MILLION)
  • TABLE 343. NORWAY CRISPR GENE EDITING MARKET SIZE, BY OFFERING, 2018-2023 (USD MILLION)
  • TABLE 344. NORWAY CRISPR GENE EDITING MARKET SIZE, BY OFFERING, 2024-2030 (USD MILLION)
  • TABLE 345. NORWAY CRISPR GENE EDITING MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 346. NORWAY CRISPR GENE EDITING MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 347. NORWAY CRISPR GENE EDITING MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 348. NORWAY CRISPR GENE EDITING MARKET SIZE, BY APPLICATION, 2024-2030 (USD